Evidence map›Paper›PMID 29410544›Full record

ReviewJournal of perinatology : official journal of the California Perinatal Association2018

Prenatal microarray analysis in right aortic arch-a retrospective cohort study and review of the literature.

Idit Maya, Amihood Singer, Hagit N Baris, Yael Goldberg, Adel Shalata, Morad Khayat, Shay Ben-Shachar, Lena Sagi-Dain

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of perinatology : official journal of the California Perinatal Association, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. The pleiotropic spectrum of proximal 16p11.2 CNVs.American journal of human genetics · 2024
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Prenatal findings and pregnancy outcome in fetuses with right and double aortic arch. A 10-year experience at a tertiary center.Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 8 institutions in 1 country.

Idit MayaRecanati Genetics Institute, Beilinson Hospital, Rabin Medical Center, Petach Tikva, Israel.
Amihood SingerCommunity Genetics, Public Health Services, Ministry of Health, Jerusalem, Israel.
Hagit N BarisThe Genetics Institute, Rambam Health Care Campus, and the Technion - Israel Institute of Technology, Haifa, Israel.
Yael GoldbergHadassah-Hebrew University Medical Center, Jerusalem, Israel.
Adel ShalataGenetics Institute, Bnai Zion Medical Center, Haifa, Israel.
Morad KhayatInstitute of Human Genetics, Haemek Medical Center, Afula, Israel.
Shay Ben-ShacharGenetic Institute, Tel Aviv Sourasky Medical Center, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Lena Sagi-DainGenetics Institute, Carmel Medical Center, Haifa, Israel. lena2303@gmail.com.ORCID http://orcid.org/0000-0002-0883-2130
Bnai Zion Medical Center · ILCarmel Medical Center · ILEmek Medical Center · ILHadassah Medical Center · ILIsrael Ministry of Health · ILRabin Medical Center · ILTechnion – Israel Institute of Technology · ILTel Aviv University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo examine the risk for clinically significant chromosomal microarray analysis (CMA) findings in fetal right aortic arch (RAA).

methodsData from all CMA analyses performed owing to isolated RAA reported to the Israeli Ministry of Health between January 2013 and September 2016 were evaluated retrospectively. Risk for abnormal CMA findings was compared with two control populations, based on both previously described 9272 pregnancies with normal ultrasound, and on a local cohort of 5541 pregnancies undergoing CMA testing owing to maternal request. In addition, Pubmed database search was conducted for original researches examining this issue.

resultsOf 94 CMA analyses performed owing to isolated RAA, six (6.4%) pathogenic findings were detected (47,XX + 21; 45,X; two 22q11.2 microdeletions; 10p15.3 microdeletion and 16p11.2 duplication). Compared with control groups, an isolated RAA yielded a significantly increased relative risk for abnormal CMA results. Literature search yielded two additional retrospective studies describing microarray testing in RAA and encompassing 57 cases. The overall risk for clinically significant CMA findings was 6.62% (10/151).

conclusionsCMA testing is indicated in cases of prenatal isolated RAA, even in the era of advanced sonographic equipment, routine biochemical screening for Down syndrome and available non-invasive prenatal testing.

Indexed as

Chromosome AberrationsMicroarray AnalysisAdultAorta, ThoracicDown SyndromeFemaleFetal DiseasesHumansPregnancyPrenatal DiagnosisRetrospective StudiesUltrasonography, Prenatal

Identifiers

PMID29410544
OpenAlexW2790312137

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.